
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
BIOTECHNOLOGY: INDIA SCENARIO AND WORLD SCENARIO – IN LAST 20 YEARS
Dr. Ajit V Pandya* and Kunjan Vora
Abstract Traditional pharmaceutical industries are now diversifying into biotechnology. Some companies are showing interest in bringing recombinant and transgenic products into the Indian market. As per the available data, about 31 companies with investment of Rs. 28500 million and turnover of Rs. 2650 million produced diverse vaccines that include tuberculosis, measles, diphtheria, pertussis, tetanus and polio. . Exports are mainly to Europe, Japan and the USA. The total turnover of the industry in 1997 was around Rs. 820 million including exports of around Rs. 600 million. India imports about 70 percent of the total enzyme consumption, majority for detergents, textiles, starch and pharmaceutical industries. Novo Nordisk and Genencor have significant percent in India. Keywords: . [Full Text Article] [Download Certificate] |
